Evaluating IV Iron Therapies for Management of Postpartum Anemia: A Comparative Study

Comparative Study Of Efficacy And Safety Of Intravenous Ferric Carboxymaltose And Iron Sucrose In The Management Of Postpartum Anemia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080987

Enrollment

Registered

2025-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Comparative Study Of Efficacy And Safety Of Intravenous Ferric Carboxymaltose And Iron Sucrose In The Management Of Postpartum Anemia: Total Sample size will be divided into two groups

Eligibility

Inclusion criteria

Inclusion criteria: All postpartum feamle consenting for study having hemoglobin 7 to 9.9g/dl Iron deficiency anemia diagnosed by complete blood count with peripheral blood smear and serum ferritin levels

Exclusion criteria

Exclusion criteria: Allergic to parenteral Iron Patient who did not give consent

Design outcomes

Primary

Measure	Time frame
Rise in hemoglobin and Serum Ferritin valuesTimepoint: 1 YEAR	—

Secondary

Measure	Time frame
Adverse Effects & Safety ProfileTimepoint: 1 YEAR	—

Countries

India

Contacts

Public ContactDr Ratnpriya

Sikkim Manipal Institute Of Medical Sciences, Gangtok

anup.p@smims.smu.edu.in9434485334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026